TMSP's subsidiary received the drug re-registration approval notice
I'm PortAI, I can summarize articles.
According to the Zhitong Finance APP, TMSP announced that its wholly-owned subsidiary Huangshan TMSP Co., Ltd. (referred to as "Huangshan TMSP") recently received the approval notice for re-registration of several drugs, including Liuwei Dihuang Wan, issued by the Anhui Provincial Drug Administration. The acquisition of the above-mentioned drug re-registration approval notice ensures the stability and continuity of the company's drug production and sales qualifications, which has positive significance for the company's subsequent production, sales, and promotion
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Zhitong The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments